{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T14:53:55Z","timestamp":1767192835821,"version":"3.37.3"},"reference-count":41,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2022,1,25]],"date-time":"2022-01-25T00:00:00Z","timestamp":1643068800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"name":"ASCO Conquer Cancer Foundation Young Investigator Award","award":["U54CA132384","U54CA132379"],"award-info":[{"award-number":["U54CA132384","U54CA132379"]}]},{"name":"VA Career Development Award","award":["1 IK2 CX002049-01"],"award-info":[{"award-number":["1 IK2 CX002049-01"]}]},{"name":"National Institute on Drug Abuse of the National Institutes of Health","award":["R03DA053541"],"award-info":[{"award-number":["R03DA053541"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,5,9]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>There is limited research on how the opioid epidemic and consequent risk reduction policies have affected pain management among cancer patients. The purpose of this study was to analyze how the Opioid Safety Initiative (OSI) implemented at the Veterans Health Administration affected opioid prescribing patterns and opioid-related toxicity.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>We performed an interrupted time series analysis of 42\u2009064 opioid-na\u00efve patients treated at the Veterans Health Administration for prostate, lung, breast, and colorectal cancer from 2011 to 2016. Segmented regression was used to evaluate the impact of the OSI on the incidence of any new opioid prescriptions, high-risk prescriptions, persistent use, and pain-related emergency department (ED) visits. We compared the cumulative incidence of adverse opioid events including an opioid-related admission or diagnosis of misuse before and after the OSI. All statistical tests were 2-sided.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>The incidence of new opioid prescriptions was 26.7% (95% confidence interval [CI]\u2009=\u200925.0% to 28.4%) in 2011 and increased to 50.6% (95% CI\u2009=\u200948.3% to 53.0%) by 2013 before OSI implementation (monthly rate of change: +3.3%, 95% CI\u2009=\u20091.3% to 4.2%, P\u2009&amp;lt;\u2009.001). After the OSI, there was a decrease in the monthly rate of change for new prescriptions (\u22123.4%, 95% CI\u2009=\u2009\u22123.9 to \u22122.9%, P\u2009&amp;lt;\u2009.001). The implementation of the OSI was associated with a decrease in the monthly rate of change of concomitant benzodiazepines and opioid prescriptions (\u22122.5%, 95% CI\u2009=\u2009\u22123.2% to \u22121.8%, P\u2009&amp;lt;\u2009.001), no statistically significant change in high-dose opioids (\u22121.2%, 95% CI\u2009=\u2009\u22123.2% to 0.9%, P\u2009=\u2009.26), a decrease in persistent opioid use (\u22125.7%, 95% CI\u2009=\u2009\u22126.8% to \u22124.7%, P\u2009&amp;lt;\u2009.001), and an increase in pain-related ED visits (+3.0%, 95% CI\u2009=\u20091.0% to 5.0%, P\u2009=\u2009.003). The OSI was associated with a decreased incidence of opioid-related admissions (3-year cumulative incidence: 0.9% [95% CI\u2009=\u20090.7% to 1.0%] vs 0.5% [95% CI\u2009=\u20090.4% to 0.6%], P\u2009&amp;lt;\u2009.001) and no statistically significant change in the incidence of opioid misuse (3-year cumulative incidence: 1.2% [95% CI\u2009=\u20091.0% to 1.3%] vs 1.2% [95% CI = 1.1% to 1.4%], P\u2009=\u2009.77).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>The OSI was associated with a relative decline in the rate of new, persistent, and certain high-risk opioid prescribing as well as a slight increase in the rate of pain-related ED visits. Further research on patient-centered outcomes is required to optimize opioid prescribing policies for patients with cancer.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/jnci\/djac017","type":"journal-article","created":{"date-parts":[[2022,1,24]],"date-time":"2022-01-24T20:11:59Z","timestamp":1643055119000},"page":"753-760","source":"Crossref","is-referenced-by-count":8,"title":["Impacts of an Opioid Safety Initiative on\u00a0US Veterans Undergoing Cancer Treatment"],"prefix":"10.1093","volume":"114","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2033-6874","authenticated-orcid":false,"given":"Lucas K","family":"Vitzthum","sequence":"first","affiliation":[{"name":"Department of Radiation Oncology, Stanford University, Stanford, CA, USA"},{"name":"Office of Research and Development, Palo Alto Veterans Affairs Medical Center, Palo Alto, CA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6594-6740","authenticated-orcid":false,"given":"Vinit","family":"Nalawade","sequence":"additional","affiliation":[{"name":"Office of Research and Development, Radiation Medicine and Applied Sciences, University of California San Diego, La Jolla, CA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7966-3090","authenticated-orcid":false,"given":"Paul","family":"Riviere","sequence":"additional","affiliation":[{"name":"Office of Research and Development, Radiation Medicine and Applied Sciences, University of California San Diego, La Jolla, CA, USA"},{"name":"San Diego Veterans Affairs Medical Center, La Jolla, CA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mallika","family":"Marar","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Stanford University, Stanford, CA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4615-3366","authenticated-orcid":false,"given":"Timothy","family":"Furnish","sequence":"additional","affiliation":[{"name":"Division of Pain Medicine, Department of Internal Medicine, University of California San Diego, La Jolla, CA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lewei A","family":"Lin","sequence":"additional","affiliation":[{"name":"VA Center for Clinical Management Research, VA Ann Arbor Healthcare System and Department of Psychiatry, University of Michigan, Ann Arbor, MI, USA"},{"name":"Addiction Center and Mental Health Innovations, Services and Outcomes Program, Department of Psychiatry, University of Michigan, Ann Arbor, MI, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3661-5296","authenticated-orcid":false,"given":"Reid","family":"Thompson","sequence":"additional","affiliation":[{"name":"Department of Radiation Medicine, Oregon Health and Sciences University, Portland, OR, USA"},{"name":"Office of Research and Development, Portland Veterans Affairs Medical Center, Portland, OR, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James D","family":"Murphy","sequence":"additional","affiliation":[{"name":"Office of Research and Development, Radiation Medicine and Applied Sciences, University of California San Diego, La Jolla, CA, USA"},{"name":"San Diego Veterans Affairs Medical Center, La Jolla, CA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2022,1,25]]},"reference":[{"year":"2020","author":"Hedegaard","key":"2022051008255866900_djac017-B1"},{"issue":"26","key":"2022051008255866900_djac017-B2","doi-asserted-by":"publisher","first-page":"697","DOI":"10.15585\/mmwr.mm6626a4","article-title":"Vital signs: changes in opioid prescribing in the United States, 2006\u20132015","volume":"66","author":"Guy","year":"2017","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"5","key":"2022051008255866900_djac017-B3","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1001\/jamainternmed.2017.0147","article-title":"Addressing the opioid epidemic in the United States: lessons from the Department of Veterans Affairs","volume":"177","author":"Gellad","year":"2017","journal-title":"JAMA Intern Med"},{"issue":"6","key":"2022051008255866900_djac017-B4","doi-asserted-by":"publisher","first-page":"367","DOI":"10.7326\/M18-1243","article-title":"Opioid prescribing in the United States before and after the centers for disease control and prevention\u2019s 2016 opioid guideline","volume":"169","author":"Bohnert","year":"2018","journal-title":"Ann Intern Med"},{"issue":"3","key":"2022051008255866900_djac017-B5","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1097\/j.pain.0000000000001773","article-title":"A delicate balance: risks vs benefits of opioids in cancer pain","volume":"161","author":"Paice","year":"2020","journal-title":"Pain"},{"issue":"5","key":"2022051008255866900_djac017-B6","doi-asserted-by":"publisher","first-page":"e433","DOI":"10.1200\/JOP.19.00675","article-title":"Bridging the gap among clinical practice guidelines for pain management in cancer and sickle cell disease","volume":"16","author":"Schatz","year":"2020","journal-title":"J Clin Oncol Oncol Pract"},{"issue":"16","key":"2022051008255866900_djac017-B7","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1200\/JCO.2013.52.5188","article-title":"Principles of opioid use in cancer pain","volume":"32","author":"Portenoy","year":"2014","journal-title":"J Clin Oncol"},{"issue":"27","key":"2022051008255866900_djac017-B8","doi-asserted-by":"crossref","first-page":"3325","DOI":"10.1200\/JCO.2016.68.5206","article-title":"Management of chronic pain in survivors of adult cancers: American Society of Clinical Oncology Clinical Practice Guideline","volume":"34","author":"Paice","year":"2016","journal-title":"J Clin Oncol"},{"issue":"3","key":"2022051008255866900_djac017-B9","doi-asserted-by":"publisher","first-page":"69","DOI":"10.15585\/mmwr.mm6603a1","article-title":"Invasive cancer incidence and survival \u2014 United States, 2013","volume":"66","author":"Henley","year":"2017","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"12","key":"2022051008255866900_djac017-B10","doi-asserted-by":"publisher","first-page":"2491","DOI":"10.1002\/cncr.31303","article-title":"Cancer pain management and the opioid crisis in America: how to preserve hard-earned gains in improving the quality of cancer pain management","volume":"124","author":"Paice","year":"2018","journal-title":"Cancer"},{"issue":"15","key":"2022051008255866900_djac017-B11","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.1001\/jama.2016.1464","article-title":"CDC guideline for prescribing opioids for chronic pain-United States, 2016","volume":"315","author":"Dowell","year":"2016","journal-title":"JAMA"},{"issue":"5","key":"2022051008255866900_djac017-B12","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1097\/j.pain.0000000000000837","article-title":"Impact of the Opioid Safety Initiative on opioid-related prescribing in veterans","volume":"158","author":"Lin","year":"2017","journal-title":"Pain"},{"issue":"1","key":"2022051008255866900_djac017-B13","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1186\/s12913-019-4642-8","article-title":"The effectiveness of prescription drug monitoring programs at reducing opioid-related harms and consequences: a systematic review","volume":"19","author":"Rhodes","year":"2019","journal-title":"BMC Health Serv Res"},{"issue":"7","key":"2022051008255866900_djac017-B14","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1001\/jamaoncol.2020.0779","article-title":"Managing cancer pain during the opioid epidemic\u2014balancing caution and compassion","volume":"6","author":"Vitzthum","year":"2020","journal-title":"JAMA Oncol"},{"year":"2018","author":"Sandbrink","key":"2022051008255866900_djac017-B15"},{"issue":"7","key":"2022051008255866900_djac017-B16","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1097\/AJP.0000000000000011","article-title":"Trends and regional variation in opioid overdose mortality among Veterans Health Administration Patients, fiscal year 2001 to 2009","volume":"30","author":"Bohnert","year":"2013","journal-title":"Clin J Pain"},{"issue":"4","key":"2022051008255866900_djac017-B17","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1097\/MLR.0b013e318202aa27","article-title":"Accidental poisoning mortality among patients in the Department of Veterans Affairs health system","volume":"49","author":"Bohnert","year":"2011","journal-title":"Med Care"},{"key":"2022051008255866900_djac017-B18"},{"issue":"7","key":"2022051008255866900_djac017-B19","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1093\/jnci\/djz200","article-title":"Predicting persistent opioid use, abuse and toxicity among cancer survivors","volume":"112","author":"Vitzthum","year":"2020","journal-title":"J Natl Cancer Inst"},{"issue":"36","key":"2022051008255866900_djac017-B20","doi-asserted-by":"crossref","first-page":"4042","DOI":"10.1200\/JCO.2017.74.1363","article-title":"New persistent opioid use among patients with cancer after curative-intent surgery","volume":"35","author":"Lee","year":"2017","journal-title":"J Clin Oncol"},{"issue":"6","key":"2022051008255866900_djac017-B21","doi-asserted-by":"publisher","first-page":"e170504","DOI":"10.1001\/jamasurg.2017.0504","article-title":"New persistent opioid use after minor and major surgical procedures in US adults","volume":"152","author":"Brummett","year":"2017","journal-title":"JAMA Surg"},{"issue":"2","key":"2022051008255866900_djac017-B22","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/j.athoracsur.2018.08.057","article-title":"Factors associated with new persistent opioid usage after lung resection","volume":"107","author":"Brescia","year":"2019","journal-title":"Ann Thorac Surg"},{"issue":"9","key":"2022051008255866900_djac017-B23","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1001\/jamainternmed.2016.3298","article-title":"Incidence of and risk factors for chronic opioid use among opioid-naive patients in the postoperative period","volume":"176","author":"Sun","year":"2016","journal-title":"JAMA Intern Med"},{"issue":"1","key":"2022051008255866900_djac017-B24","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1093\/ije\/dyw098","article-title":"Interrupted time series regression for the evaluation of public health interventions: a tutorial","volume":"46","author":"Lopez Bernal","year":"2017","journal-title":"Int J Epidemiol"},{"volume-title":"A Language and Environment for Statistical Computing","year":"2019","key":"2022051008255866900_djac017-B25"},{"issue":"5","key":"2022051008255866900_djac017-B26","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1001\/JAMA.2017.8913","article-title":"New data on opioid use and prescribing in the United States","volume":"318","author":"Schuchat","year":"2017","journal-title":"JAMA"},{"issue":"3","key":"2022051008255866900_djac017-B27","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/j.jpainsymman.2014.07.007","article-title":"Avoidable and unavoidable visits to the emergency department among patients with advanced cancer receiving outpatient palliative care","volume":"49","author":"Delgado-Guay","year":"2015","journal-title":"J Pain Symptom Manage"},{"issue":"1","key":"2022051008255866900_djac017-B28","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.jpain.2015.10.002","article-title":"The impact of opioid risk reduction initiatives on high-dose opioid prescribing for patients on chronic opioid therapy","volume":"17","author":"Von Korff","year":"2016","journal-title":"J Pain"},{"issue":"9","key":"2022051008255866900_djac017-B29","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1001\/jamainternmed.2017.2468","article-title":"Improving adherence to long-term opioid therapy guidelines to reduce opioid misuse in primary care: a cluster-randomized clinical trial","volume":"177","author":"Liebschutz","year":"2017","journal-title":"JAMA Intern Med"},{"issue":"7","key":"2022051008255866900_djac017-B30","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1001\/jamaoncol.2020.0804","article-title":"Fewer oncology patients receive opioids in states with mandatory access prescription drug monitoring programs","volume":"6","author":"Graetz","year":"2020","journal-title":"JAMA Oncol"},{"issue":"8","key":"2022051008255866900_djac017-B31","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1001\/jamaoncol.2020.2211","article-title":"Changes in opioid prescribing patterns among generalists and oncologists for Medicare Part D beneficiaries from 2013 to 2017","volume":"6","author":"Agarwal","year":"2020","journal-title":"JAMA Oncol"},{"issue":"1","key":"2022051008255866900_djac017-B32","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1111\/pme.12907","article-title":"Cohort study of the impact of high-dose opioid analgesics on overdose mortality","volume":"17","author":"Dasgupta","year":"2016","journal-title":"Pain Med"},{"key":"2022051008255866900_djac017-B33","doi-asserted-by":"publisher","first-page":"h2698","DOI":"10.1136\/bmj.h2698","article-title":"Benzodiazepine prescribing patterns and deaths from drug overdose among US veterans receiving opioid analgesics: case-cohort study","volume":"350","author":"Park","year":"2015","journal-title":"BMJ"},{"issue":"7","key":"2022051008255866900_djac017-B34","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1097\/AJP.0000000000000021","article-title":"The role of opioid prescription in incident opioid abuse and dependence among individuals with chronic noncancer pain: The role of opioid prescription","volume":"30","author":"Edlund","year":"2014","journal-title":"Clin J Pain"},{"issue":"3","key":"2022051008255866900_djac017-B35","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1046\/j.1525-1497.2002.10435.x","article-title":"Use of opioid medications for chronic noncancer pain syndromes in primary care","volume":"17","author":"Reid","year":"2002","journal-title":"J Gen Intern Med"},{"issue":"5.5","key":"2022051008255866900_djac017-B36","doi-asserted-by":"publisher","first-page":"595","DOI":"10.6004\/jnccn.2019.5010","article-title":"Managing pain in patients and survivors: challenges within the United States opioid crisis","volume":"17","author":"Paice","year":"2019","journal-title":"J Natl Compr Canc Netw"},{"issue":"16","key":"2022051008255866900_djac017-B37","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1200\/JCO.2013.52.5196","article-title":"Under- or overtreatment of pain in the patient with cancer: how to achieve proper balance","volume":"32","author":"Paice","year":"2014","journal-title":"J Clin Oncol"},{"issue":"12","key":"2022051008255866900_djac017-B38","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1200\/JCO.18.00938","article-title":"Trends in opioid use among older survivors of colorectal, lung, and breast cancers","volume":"37","author":"Salz","year":"2019","journal-title":"J Clin Oncol"},{"issue":"7","key":"2022051008255866900_djac017-B39","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1001\/jamaoncol.2020.0799","article-title":"Opioid associated deaths in cancer survivors: a population study of the opioid epidemic","volume":"6","author":"Chino","year":"2020","journal-title":"JAMA Oncol"},{"issue":"9","key":"2022051008255866900_djac017-B40","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1093\/jnci\/djz233","article-title":"Emergency department visits for opioid overdoses among patients with cancer","volume":"112","author":"Jairam","year":"2020","journal-title":"J Natl Cancer Inst."},{"issue":"26","key":"2022051008255866900_djac017-B41","doi-asserted-by":"crossref","first-page":"2948","DOI":"10.1200\/JCO.21.00476","article-title":"US trends in opioid access among patients with poor prognosis cancer near the end-of-life","volume":"39","author":"Enzinger","year":"2021","journal-title":"J Clin Oncol"}],"container-title":["JNCI: Journal of the National Cancer Institute"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jnci\/advance-article-pdf\/doi\/10.1093\/jnci\/djac017\/42625023\/djac017.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jnci\/article-pdf\/114\/5\/753\/43623270\/djac017.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jnci\/article-pdf\/114\/5\/753\/43623270\/djac017.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,10]],"date-time":"2022-05-10T08:31:30Z","timestamp":1652171490000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jnci\/article\/114\/5\/753\/6515294"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,25]]},"references-count":41,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2022,1,25]]},"published-print":{"date-parts":[[2022,5,9]]}},"URL":"https:\/\/doi.org\/10.1093\/jnci\/djac017","relation":{},"ISSN":["0027-8874","1460-2105"],"issn-type":[{"type":"print","value":"0027-8874"},{"type":"electronic","value":"1460-2105"}],"subject":[],"published-other":{"date-parts":[[2022,5,1]]},"published":{"date-parts":[[2022,1,25]]}}}